PharmaLegacy Laboratories (Shanghai) Co., Ltd was founded in 10 years ago, After a period of rapid development, it has developed into a considerable size and effectiveness company of DMPKandRespiratory Disease Model, NOw it is benchmark companies in 商务服务,医疗服务,医疗保健 industry.

   Innovation is the cornerstones of PharmaLegacy Laboratories (Shanghai) Co., Ltds success. In the future, PharmaLegacy also hope to continue to innovate, for the majority of customers to provide Non-Human Primates modelsservice. Over the years, PharmaLegacy always believe that only adhere to innovation and professional, in order to better meet customer demand for The latest launch DMPK. details:Drug Metabolism and Pharmacokinetics (DMPK) deals with the fate of a drug administered by various routes in the living organism (humans and laboratory animals). It involves improving understanding of DMPK properties of the drug in experimental animals and humans and predict exposure-effect relationship with respect to time. In the past, suboptimal characterization and understanding of DMPK properties of drugs led to a much higher attrition/failure rate of drugs in the clinic. PharmaLegacy can provide a complete complementary PK/ADME service. Our team of DMPK scientists are dedicated to both discovery and development. This coupled with state-of-the-art instrumentation and supported by an AAALAC accredited vivarium, assists our clients from lead candidate selection through development and ensures a high quality of DMPK studies with cost-efficiency and fast turnaround. DMPK deals with the effect of human body on the drug. PharmaLegacy offers the clients a broad spectrum of high quality services in the areas of in vitro ADME, in vivo pharmacokinetics and bioanalysis services, with cost-efficiency and fast turnaround. The test articles range from small molecules to large molecules, such as protein and antibody. The animal species involved are non-human primate, canine, mice, rat, rabbit, guinea pig and mini pig.

   Adhering to the "Customer Supreme Forge Ahead" management idea, PharmaLegacy insists on providing the best quality and service of Non-Human Primates models,Rheumatoid arthritis Modelx2a38631n with the "customer first" principle. Wholeheartedly welcome your patronage! Official website address: www.pharmalegacy.com

PharmaLegacy Laboratories is a leading speciality pharmacology Contract Research Organization located in Shanghai Zhangjiang High-Tech Park, China. PharmaLegacy is equipped with a world-class facility, working to international pharmaceutical industrial standards. PharmaLegacy provides preclinical in vivo pharmacology efficacy services as well a therapeutic antibody discovery service program. Our state-of-the-art platforms include:· Pioneering work using CD34+ humanized mice that carry a human immune system, to test biologics for immuno-oncology therapeutic efficacy· An NHP platform for therapeutic biologics testing in a variety of immune diseases · An advanced antibody discovery platform based on single B cell antibody sequencing · An internationally recognized Bone/Orthopaedics platform to test both hard tissue disease therapeutic candidates and medical devicesPharmaLegacy offers a full range of preclinical pharmacology services for evaluating pharmacological effects of drug candidates in the areas of inflammation/auto-Immune diseases, lung injury, liver/metabolic diseases and oncology. Our NHP platform and CD34+ humanized mice models have helped dozens of clients with IND filings